Patient-reported outcomes 12 years after localized prostate cancer treatment
BACKGROUND<br> Long-term patient-reported outcomes are needed to inform treatment decisions for localized prostate cancer. <br><br> METHODS<br> Patient-reported outcomes of 1643 randomly assigned participants in the ProtecT (Prostate Testing for Cancer and Treatment) trial we...
Main Authors: | Donovan, JL, Hamdy, FC, Lane, JA, Young, GJ, Metcalfe, C, Walsh, EI, Davis, M, Steuart-Feilding, T, Blazeby, JM, Avery, KNL, Martin, RM, Bollina, P, Doble, A, Doherty, A, Gillatt, D, Gnanapragasam, V, Hughes, O, Kockelbergh, R, Kynaston, H, Paul, A, Paez, E, Powell, P, Rosario, DJ, Rowe, E, Mason, M, Catto, JWF, Peters, TJ, Wade, J, Turner, EL, Williams, NJ, Oxley, J, Staffurth, J, Bryant, RJ, Neal, DE |
---|---|
Format: | Journal article |
Language: | English |
Published: |
NEJM Group
2023
|
Similar Items
-
Fifteen-year outcomes after monitoring, surgery, or radiotherapy for prostate cancer
by: Hamdy, FC, et al.
Published: (2023) -
Active monitoring, radical prostatectomy and radical radiotherapy in PSA-detected clinically localised prostate cancer: The ProtecT three-arm RCT
by: Hamdy, FC, et al.
Published: (2020) -
Ten-year mortality, disease progression, and treatment-related side effects in men with localised prostate cancer from the protecT randomised controlled trial according to treatment received
by: Neal, D, et al.
Published: (2019) -
The ProtecT trial: Analysis of the patient cohort, baseline risk stratification and disease progression
by: Young, GJ, et al.
Published: (2020) -
10-year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer
by: Hamdy, F, et al.
Published: (2016)